27.26M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy.

Similar securities

Based on sector and market capitalization

Report issue